Milestone Pharmaceuticals Inc. (MIST)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Research and development, net of tax credits | 3,669 | 4,978 | 3,963 | 2,815 |
| General and administrative | 3,759 | 5,167 | 3,742 | 5,046 |
| Commercial | 5,103 | 10,378 | 1,911 | 1,801 |
| Loss from operations | -12,531 | -20,523 | -9,616 | -9,662 |
| Interest income | 516 | 697 | 1,080 | 1,186 |
| Interest expense | 951 | 935 | 903 | 887 |
| Net loss and comprehensive loss | -12,966 | -20,761 | -9,439 | -9,363 |
| Earnings per share, basic | -0.2 | -0.31 | -0.14 | -0.14 |
| Earnings per share, diluted | -0.2 | -0.31 | -0.14 | -0.14 |